ENO2 and cancer: The results showed that GA significantly increased the expression level of selected cancer-related proteins, including enolase-2 (1.25-fold, p = 0.00043), CapG (1.3-fold, p = 0.045), galectin-3 (1.28-fold, p = 0.00004), and cathepsin D (1.68-fold, p = 0.00049), compared to the untreated cells, the control (Figure 5G).